City

London (1)

Manchester (1)

Newcastle (1)

Sutton (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Institute of Cancer Research, United Kingdom (1)

University College, London (1)

University Hospital, Basel, Switzerland (1)

Collaborator

Verastem, Inc. (1)

Intervention

carboplatin (1)

defactinib (1)

vs-6766 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (3)

Study Type

Interventional (2)

Observational (1)

endometrioid carcinoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Ovarian Cancer, Relapsed Ovarian Cancer, Fallopian Tube Cancer Trial (Carboplatin)

Not yet recruiting

Ovarian Cancer
+6 more

Carboplatin

(no location specified)

Oct 27, 2022

NSCLC, Low Grade Serous Ovarian Cancer, Endometrioid Carcinoma Trial in United Kingdom (VS-6766, Defactinib)

Recruiting

NSCLC
+3 more

Manchester, Greater Manchester, United Kingdom
+4 more

Mar 18, 2022

Endometriosis and Frequency of Endometriosis-associated Ovarian

Withdrawn

Endometrioid Carcinoma
+2 more

(no location specified)

Mar 31, 2015